These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18044711)

  • 41. Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas.
    Lee H; Rhee H; Kang HJ; Kim HS; Min BS; Kim NK; Kim H
    Am J Clin Pathol; 2008 May; 129(5):772-9. PubMed ID: 18426738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and evaluation of antigen capture ELISA for early clinical diagnosis of chikungunya.
    Shukla J; Khan M; Tiwari M; Sannarangaiah S; Sharma S; Rao PV; Parida M
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):142-9. PubMed ID: 19748424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
    Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
    Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
    Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-acetyl-beta-D-hexosaminidase and its isoenzymes A and B in blood serum and urine, as a potential colon cancer markers.
    Szajda SD; Borzym-Kluczyk M; Snarska J; Puchalski Z; Zwierz K
    Hepatogastroenterology; 2009; 56(94-95):1287-98. PubMed ID: 19950779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer cell-expressed immunoglobulins: CA215 as a pan cancer marker and its diagnostic applications.
    Lee G
    Cancer Biomark; 2009; 5(3):137-42. PubMed ID: 19407368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions.
    Konda A; Duffy MC
    Gastroenterol Clin North Am; 2008 Mar; 37(1):191-213, viii. PubMed ID: 18313546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colorectal cancer detection by measuring DNA from exfoliated colonocytes obtained by direct contact with rectal mucosa.
    Loktionov A; Bandaletova T; Llewelyn AH; Dion C; Lywood HG; Lywood RC; Rockall TA; Stebbing JF; Broughton M; Caffarey S; Marks CG
    Int J Oncol; 2009 Feb; 34(2):301-11. PubMed ID: 19148463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stool test for colorectal cancer screening: what is going on?
    Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
    Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices.
    Velayos F
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):817-25. PubMed ID: 19090741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
    Liu C; Guo J; Qu L; Bing D; Meng L; Wu J; Shou C
    Cancer Lett; 2008 Sep; 269(1):148-58. PubMed ID: 18586385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An enzyme-linked immunosorbent assay for human carcinoembryonic antigen-related cell adhesion molecule 8, a biological marker of granulocyte activities in vivo.
    Zhao L; Xu S; Fjaertoft G; Pauksen K; Håkansson L; Venge P
    J Immunol Methods; 2004 Oct; 293(1-2):207-14. PubMed ID: 15541289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of an enzyme-linked immunosorbent assay for fecal bile acid.
    Matsumoto M; Takei H; Kanoh M; Kamano T; Maeda M
    Rinsho Byori; 2004 Nov; 52(11):891-6. PubMed ID: 15658467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A neural network approach to the early detection of cancer.
    Dwarakanath S; Ferris CD; Pierre JW; Asplund RO; Curtis DL
    Biomed Sci Instrum; 1994; 30():239-43. PubMed ID: 7948643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retraction. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.
    Schoen RE; Weissfeld JL; Sokoll LJ; Chan DW; Cannon GW; Getzenberg RH
    Cancer Res; 2013 Jan; 73(2):1034. PubMed ID: 23271721
    [No Abstract]   [Full Text] [Related]  

  • 59. A novel screening test for colon cancer: Talin-1.
    Bostanci O; Kemik O; Kemik A; Battal M; Demir U; Purisa S; Mihmanli M
    Eur Rev Med Pharmacol Sci; 2014; 18(17):2533-7. PubMed ID: 25268101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. More convenient colon-cancer testing.
    Health News; 2003 Nov; 9(11):11. PubMed ID: 14619821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.